Related Experiment Video
Updated: Mar 26, 2026
06:39
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
1.6K
A new dimeric anthraquinone from endophytic Talaromyces sp. YE3016
Xiao-Song Xie1, Xiao-Wei Fang1, Rong Huang2
1a Key Laboratory for Microbial Resources of the Ministry of Education, Yunnan Institute of Microbiology , Yunnan University , Kunming , P.R. China.
Natural Product Research
|January 28, 2016
Summary
A novel dimeric anthraquinone was discovered in fungi. This new compound and related molecules showed moderate cytotoxic activity against the MCF-7 cancer cell line, suggesting potential therapeutic applications.
Area of Science:
- Natural Product Chemistry
- Mycology
- Pharmacology
Background:
- Endophytic fungi are a rich source of bioactive natural products.
- Anthraquinones are a class of compounds known for diverse biological activities.
- Talaromyces species are recognized for producing secondary metabolites.
Purpose of the Study:
- To isolate and characterize new compounds from endophytic fungi.
- To evaluate the cytotoxic potential of isolated compounds.
Main Methods:
- Solid-state fermentation of Talaromyces sp. YE 3016.
- Isolation and purification of fungal metabolites.
- Structure elucidation using spectroscopic analysis (e.g., NMR, MS).
- Cytotoxicity assays against MCF-7 cell line.
Main Results:
- A new unsymmetrical dimeric anthraquinone, 3-demethyl-3-(2-hydroxypropyl)-skyrin (1), was isolated.
- Five known compounds (skyrin, oxyskyrin, emodin, etc.) were identified.
- Compounds 1-3 demonstrated moderate cytotoxic effects on MCF-7 cells.
Conclusions:
- The endophytic fungus Talaromyces sp. YE 3016 produces a novel dimeric anthraquinone.
- The isolated compounds, particularly 1-3, possess cytotoxic properties warranting further investigation.
